TSE:KPT KP Tissue (KPT) Stock Price, News & Analysis C$8.05 -0.10 (-1.23%) As of 03/28/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About KP Tissue Stock (TSE:KPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KP Tissue alerts:Sign Up Key Stats Today's RangeC$8.01▼C$8.1550-Day RangeC$7.78▼C$8.1852-Week RangeC$7.66▼C$8.88Volume11,952 shsAverage Volume14,123 shsMarket CapitalizationC$80.45 millionP/E Ratio12.60Dividend Yield8.94%Price TargetC$8.67Consensus RatingHold Company OverviewKP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Metro, White Swan, White Cloud, Embassy, Satinelle, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.Read More… Remove Ads KP Tissue Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks8th Percentile Overall ScoreKPT MarketRank™: KP Tissue scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingKP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageKP Tissue has only been the subject of 1 research reports in the past 90 days.Read more about KP Tissue's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of KP Tissue is 12.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.58.Price to Earnings Ratio vs. SectorThe P/E ratio of KP Tissue is 12.60, which means that it is trading at a more expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 10.99.Price to Earnings Growth RatioDue to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.Price to Book Value per Share RatioKP Tissue has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for KPT. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipKP Tissue is a leading dividend payer. It pays a dividend yield of 9.15%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthKP Tissue does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of KP Tissue is 112.73%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about KP Tissue's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for KPT. News and Social Media2.1 / 5News SentimentN/A News SentimentKP Tissue has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Consumer Defensive companies.News Coverage This WeekMarketBeat has tracked 1 news article for KP Tissue this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, KP Tissue insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.14% of the stock of KP Tissue is held by insiders.Percentage Held by InstitutionsOnly 8.61% of the stock of KP Tissue is held by institutions.Read more about KP Tissue's insider trading history. Receive KPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter. Email Address KPT Stock News HeadlinesCanadian companies must think twice before moving to the United StatesMarch 17, 2025 | theglobeandmail.comCIBC Reaffirms Their Hold Rating on KP Tissue (KPT)March 7, 2025 | markets.businessinsider.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. March 30, 2025 | Porter & Company (Ad)KP Tissue reports fourth-quarter loss compared with a profit a year earlierMarch 5, 2025 | msn.comCould Trump tariffs cause COVID-19-like run on toilet paper? Leading Canadian producer thinks soFebruary 14, 2025 | theglobeandmail.com3 Canadian Dividend Stocks to Consider Adding to Your TFSA in 2025January 14, 2025 | msn.comKP Tissue Inc.: KP Tissue Releases Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deKP Tissue announces senior note financing to redeem previous onesOctober 28, 2024 | msn.comSee More Headlines KPT Stock Analysis - Frequently Asked Questions How have KPT shares performed this year? KP Tissue's stock was trading at C$8.23 on January 1st, 2025. Since then, KPT shares have decreased by 2.2% and is now trading at C$8.05. View the best growth stocks for 2025 here. How do I buy shares of KP Tissue? Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of KP Tissue own? Based on aggregate information from My MarketBeat watchlists, some other companies that KP Tissue investors own include Constellation Software (CSU), Intact Financial (IFC), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Wheaton Precious Metals (WPM) and Vermilion Energy (VET). Industry, Sector and Symbol Stock ExchangeTSE SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolTSE:KPT CIKN/A Webkptissueinc.com Phone+1-905-8126900FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$8.67 High Stock Price TargetC$9.00 Low Stock Price TargetC$8.50 Potential Upside/Downside+7.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.64 Trailing P/E Ratio12.60 Forward P/E Ratio18.30 P/E Growth-0.88Net IncomeC$6.38 million Net MarginsN/A Pretax MarginN/A Return on Equity9.05% Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio1.23 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$7.08 per share Price / Book1.14Miscellaneous Outstanding Shares9,994,200Free FloatN/AMarket CapC$80.45 million OptionableNot Optionable Beta0.37 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (TSE:KPT) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KP Tissue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KP Tissue With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.